Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.49 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 2/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.46 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.46 |
| ▸ | DHFR | P00374 | 1/20 | 0.46 |
| ▸ | MPO | P05164 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.46 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL1716527 | 0.98 | ESR1 (0.47) | ESR1ESR2ALDH1A1HSD17B10KDM4E | |
| Hydrazine SCHEMBL9506838 | 0.96 | ESR1 (0.46) | ESR1ESR2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL2300929 | 0.88 | ALDH1A1 (0.50) | ESR1ESR2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL7430270 | 0.82 | MYC (0.49) | ALDH1A1HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL29563004 | 0.82 | MYC (0.52) | ALDH1A1HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL7124951 | 0.81 | TRPA1 (0.48) | ESR1ESR2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL29677294 | 0.81 | ALDH1A1 (0.54) | ALDH1A1HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL93382 | 0.81 | ALDH1A1 (0.54) | ALDH1A1HSD17B10KDM4EHPGDKMT2A | |
| SCHEMBL9864607 | 0.81 | ESR1 (0.52) | ESR1ESR2ALDH1A1HSD17B10KDM4E | |
| SCHEMBL29515031 | 0.81 | KMT2A (0.52) | ESR1ESR2ALDH1A1HSD17B10KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 689 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250304541-A1 | METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME | Icrom S.R.L. (IT) | 2025-10-02 | — | — | US | claimed |
| CN-119504594-A | Dexmedetomidine hydrochloride raw material and injection preparation method | 江西赣南海欣药业股份有限公司 | 2025-02-25 | — | — | CN | claimed |
| CN-117986232-A | Oxime ester photoinitiator, preparation method and application thereof | 常州强力电子新材料股份有限公司 | 2024-05-07 | — | — | CN | claimed |
| CN-115586282-A | Method for quantifying trace silicon hydroxyl in MQ silicon resin | 杭州师范大学 | 2023-01-10 | — | — | CN | claimed |
| CN-110922313-A | Method for continuously producing aromatic ketone | 连云港德洋化工有限公司 | 2020-03-27 | — | — | CN | claimed |
| CN-109851492-A | The synthetic method of 3,5- dimethyl benzoyl chlorides | 山东凯盛新材料股份有限公司 | 2019-06-07 | — | — | CN | claimed |
| CN-109608400-A | A kind of synthetic method of dexmedetomidine hydrochloride | 辰欣药业股份有限公司 | 2019-04-12 | — | — | CN | claimed |
| CN-109134241-A | The industrial process of 3,5- dimethyl benzoyl chloride | 山东凯盛新材料股份有限公司 | 2019-01-04 | — | — | CN | claimed |
| CN-104693062-B | Phenylacetylene derivatives and preparation of the side base with ester group, polymerization and methods for using them | 哈尔滨工程大学 | 2017-10-03 | — | — | CN | claimed |
| CN-104910039-A | Functional phenylacetylene compound and preparation method thereof | UNIV HARBIN ENG | 2015-09-16 | — | — | CN | claimed |
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | LANXESS DEUTSCHLAND GMBH (DE) | 2001-08-16 | — | — | US | claimed |
| CN-1308050-A | Preparation method of 3,5-di (trifluoromethyl) benzoyl chloride and new 3,5-di(triahlo) benzoylate A and 3,5-dimethyl benzoylate A | BAYER AG (DE) | 2001-08-15 | — | — | CN | claimed |
| EP-0639559-B1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM & HAAS (US) | 1997-10-15 | — | — | EP | claimed |
| EP-0639559-A1 | Preparation of 1,2-diacyl-2-(t-alkyl)hydrazines | ROHM AND HAAS COMPANY (US) | 1995-02-22 | — | — | EP | claimed |
| US-5334724-A | Preparation of substituted 2-chloropyridines | BAYER AKTIENGESELLSCHAFT (DE) | 1994-08-02 | — | — | US | claimed |
| EP-0438691-B1 | Process for the preparation of substituted 2-chloropyridines | BAYER AG (DE) | 1994-02-16 | — | — | EP | claimed |
| WO-1993014055-A1 | PREPARATION OF 2,5-DICHLOROBENZOPHENONES | MAXDEM INCORPORATED (US) | 1993-07-22 | — | — | WO | claimed |
| US-5210313-A | Friedel crafts aryloylation of 1,4-dichlorobenzene and Lewis acids | MAXDEM INCORPORATED (US) | 1993-05-11 | — | — | US | claimed |
| EP-0438691-A1 | Process for the preparation of substituted 2-chloropyridines | BAYER AG (DE) | 1991-07-31 | — | — | EP | claimed |
| US-4272502-A | Process for preparing gaseous hydrogen chloride from dilute aqueous hydrochloric acid | CHEMISCHE WERKE HULS AKTIENGESELLSCHAFT (DE) | 1981-06-09 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010014759-A1 | Free radical chlorination; fluorination with hydrogen fluoride and/or antimony pentafluoride; converting the benzoyl fluoride to chloride by reacting with silicon tetrachloride in lewis acid; chemical intermediates | SCLY, SSB, CLIC4 | ESR1 2480/4885ESR2 2026/4885ALDH1A1 3242/4885 |
| US-20250304541-A1 | METHYLENE BLUE HAVING A REDUCED CONTENT OF N-NITROSO-AZURE B IMPURITY AND PROCESS FOR OBTAINING THE SAME | MMAB, HBB, MB | ESR1 3226/4885ESR2 2117/4885ALDH1A1 702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.